Michael G. Oefelein MD Clinical Trials

Bakersfield, California 93301-2284

2 studies enrolling now · 3 studies all time

What they study most

Bladder Cancer, High-Risk Non-Muscle-Invasive Bladder Cancer, Intermediate Risk Non-Muscle Invasive Bladder Cancer, Non Muscle Invasive Bladder Cancer, Urologic Cancer, Urothelial Carcinoma

Studies at this site

• Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer — Recruiting now
• Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC — Recruiting now
• A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT — Running, not enrolling